Form 8-K - Current report:
SEC Accession No. 0001193125-20-276994
Filing Date
2020-10-26
Accepted
2020-10-26 16:34:03
Documents
15
Period of Report
2020-10-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d71827d8k.htm   iXBRL 8-K 29403
2 EX-99.1 d71827dex991.htm EX-99.1 68461
3 EX-99.2 d71827dex992.htm EX-99.2 8606
7 GRAPHIC g71827img1.jpg GRAPHIC 8130
  Complete submission text file 0001193125-20-276994.txt   271051

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acet-20201026.xsd EX-101.SCH 3074
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20201026_lab.xml EX-101.LAB 18889
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20201026_pre.xml EX-101.PRE 11863
8 EXTRACTED XBRL INSTANCE DOCUMENT d71827d8k_htm.xml XML 3468
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 201261071
SIC: 2834 Pharmaceutical Preparations